Trial Profile
Androgen Receptor Targeting in Mantle Cell Lymphoma: A Pilot Trial of Enzalutamide
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 16 Jul 2021 Status changed from active, no longer recruiting to discontinued.
- 22 Dec 2020 Planned End Date changed from 1 Jul 2023 to 1 Jul 2021.
- 28 Mar 2019 Status changed from recruiting to active, no longer recruiting.